(MENAFN - PR Newswire)
DUBLIN, Feb. 5, 2019 /PRNewswire/ --
The "Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
Global Active Pharmaceutical Ingredients market accounted for $151.89 billion in 2017 and is expected to reach $308.48 billion by 2026 growing at a CAGR of 8.2% from 2017 to 2026.
Increase in incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals are some factors fueling the market growth. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth.
Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. Active Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
Amongst Customer Base, Generic segment accounted for significant market share during the forecast period. Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase.
By geography, Asia Pacific dominated the market due to the rising healthcare spending which has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares across the region.
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered: 1 Executive Summary2 Preface2.1 Abstract2.2 Stake Holders2.3 Research Scope2.4 Research Methodology2.5 Research Sources3 Market Trend Analysis3.1 Introduction3.2 Drivers3.3 Restraints3.4 Opportunities3.5 Threats3.6 Application Analysis3.7 Emerging Markets3.8 Futuristic Market Scenario 4 Porters Five Force Analysis4.1 Bargaining power of suppliers4.2 Bargaining power of buyers4.3 Threat of substitutes4.4 Threat of new entrants4.5 Competitive rivalry 5 Global Active Pharmaceutical Ingredients Market, By Drug Type5.1 Introduction5.2 Generic Prescription5.3 Innovative Drugs5.4 Over-the-counter (OTC) Drugs5.5 Prescription Drugs5.6 Potency5.6.1 Low to Moderate Potency5.6.2 Potent to Highly Potent 6 Global Active Pharmaceutical Ingredients Market, By API Formulation6.1 Introduction6.2 Innovative API6.3 Generic API 7 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer7.1 Introduction7.2 Contract Manufacturers7.3 Captive Manufacturers7.4 Merchant API Manufacturers7.4.1 Generic Merchant API Manufacturers7.4.2 Innovative Merchant API Manufacturers8 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis8.1 Introduction8.2 Biotech Active Pharmaceutical Ingredients8.2.1 Type184.108.40.206 Biosimilars220.127.116.11 Innovative Biotech APIs8.2.2 Expression System18.104.22.168 Insect Expression Systems22.214.171.124 Mammalian Expression Systems126.96.36.199 Microbial Expression Systems188.8.131.52 Plant Expression Systems184.108.40.206 Yeast Expression Systems8.2.3 Product220.127.116.11 Blood Factors18.104.22.168 Cytokines22.214.171.124 Fusion Proteins126.96.36.199 Hormones and Growth Factors188.8.131.52 Monoclonal Antibodies184.108.40.206 Therapeutic Enzymes220.127.116.11 Vaccines8.3 Synthetic Active Pharmaceutical Ingredients8.3.1 Generic Synthetic APIs8.3.2 Innovative Synthetic APIs 9 Global Active Pharmaceutical Ingredients Market, By API Type9.1 Introduction9.2 Biological API9.3 Chemical API 10 Global Active Pharmaceutical Ingredients Market, By Molecule10.1 Introduction10.2 Large Molecule10.3 Small Molecule 11 Global Active Pharmaceutical Ingredients Market, By Application11.1 Introduction11.2 Anti-diabetic Drugs11.3 Cardiovascular Disease11.4 Central Nervous System and Neurological Disorders11.5 Diabetes11.6 Endocrinology11.7 Gastrointestinal Disorders11.8 Musculoskeletal drugs11.9 Non-steroidal Anti-inflammatory Drugs11.10 Oncology11.11 Orthopedic Disorders11.12 Respiratory11.13 Urology11.14 Other Applications 12 Global Active Pharmaceutical Ingredients Market, By Geography12.1 Introduction12.2 North America12.2.1 US12.2.2 Canada12.2.3 Mexico12.3 Europe12.3.1 Germany12.3.2 UK12.3.3 Italy12.3.4 France12.3.5 Spain12.3.6 Rest of Europe12.4 Asia Pacific12.4.1 Japan12.4.2 China12.4.3 India12.4.4 Australia12.4.5 New Zealand12.4.6 South Korea12.4.7 Rest of Asia Pacific12.5 South America12.5.1 Argentina12.5.2 Brazil12.5.3 Chile12.5.4 Rest of South America12.6 Middle East & Africa12.6.1 Saudi Arabia12.6.2 UAE12.6.3 Qatar12.6.4 South Africa12.6.5 Rest of Middle East & Africa 13 Key Developments 13.1 Agreements, Partnerships, Collaborations and Joint Ventures13.2 Acquisitions & Mergers13.3 New Product Launch13.4 Expansions13.5 Other Key Strategies 14 Company Profiling 14.1 Teva Active Pharmaceutical Industries Limited14.2 Ranbaxy Laboratories14.3 Pfizer, Inc14.4 Novartis14.5 Mylan N.V14.6 Lupin14.7 Dr. Reddy's Lab14.8 Boehringer Ingelheim GmbH14.9 Aurobindo pharma14.10 Albemarle Corporation14.11 Ceva Animal Health, Inc.14.12 Virbac14.13 Sun Pharmaceutical Industries Ltd.14.14 Merck Animal Health (U.S.)14.15 Elanco Animal Health (U.S.)14.16 Zoetis (U.S.)14.17 Merial Inc. (Sanofi) (France)14.18 Bioniche Animal Health (Canada)14.19 Bayer Healthcare (Germany)14.20 ELI Lilly and Company14.21 Glaxosmithkline PLC14.22 Abbvie Inc.14.23 Sanofi14.24 Bristol-Myers Squibb For more information about this report visit https://www.researchandmarkets.com/research/z5m9w5/global_active?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Also from this source Feb 05, 2019, 19:30 ET Global Wireline Services Market 2016-2018 & 2026: Market... Feb 05, 2019, 19:15 ET $12.36 Bn Water Treatment Technologies Market - Global Forecast... Explore More news releases in similar topics
- All Entertainment & Media
- All Health
- Medical Pharmaceuticals
- General Business